LSLauren Skvarca

Lauren Skvarca

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lauren Skvarca has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Placental Pathogens Associated With Adverse Maternal and Neonatal Outcomes

    by Alicia Liu, Caitlin Little, Talia Dubowitz, Malinda Schaeffer, Lauren Skvarca, Anne-Marie Rick, Thomas Hooven, Michael Morowitz, Sharon L Hillier, Harold C Wiesenfeld, et al.

    Background: Bacterial infection at the maternal-fetal interface contributes to adverse pregnancy outcomes, including preterm birth, chorioamnionitis, and sepsis. Despite evolving obstetric practices that may influence microbial patterns, recommended clinical algorithms for prophylaxis and treatment rely on outdated data. Furthermore, the pathogenic organisms associated with adverse outcomes remain incompletely characterized. Methods: We conducted a retrospective study of placental cultures from a high-risk obstetric cohort from a single hospital system between 2014 and 2019 (n = 714). Placental cultures were obtained from deliveries at high risk for infection: (eg, preterm birth or suspected chorioamnionitis). Placental cultures were stratified into pathogenic and nonpathogenic. Associated clinical outcomes, histopathology, and antimicrobial susceptibility patterns were compared. Results: Pathogenic organisms were identified in 69% of cultures (492 of 714). Group B Streptococcus (n = 161; 22.5% of total isolates) and Escherichia coli (n = 53; 7.4% of total isolates) were the most common pathogens isolated; we also identified additional pathogens, including Enterococcus faecalis (n = 44), Haemophilus (n = 37), Prevotella (n = 32), and Bacteroides species (n = 23). Pathogenic cultures were correlated with significantly higher rates of composite adverse maternal (27.0% vs 17.6%; P = .006) and neonatal (78.9% vs 60.6%; P < .001) outcomes, as well as histopathologic chorioamnionitis (72.5% vs 60.9%; P = .003). Antimicrobial resistance for recommended empiric regimens ranged from 47.1% to 87.8%. Conclusions: Bacterial pathogens isolated from the placenta in high-risk pregnancies are associated with perinatal morbidity. Group B Streptococcus and E coli remain common, and E faecalis, Haemophilus spp, and anaerobes such as Prevotella may represent emerging pathogens underrecognized in contemporary obstetric practice. Placental cultures may serve as a valuable surveillance tool for informing empiric antibiotic strategies in pregnancy.

  • Open Access

    Vaccine strains of Rift Valley fever virus exhibit attenuation at the maternal-fetal placental interface

    by Cynthia M. McMillen, Christina Megli, Rebecca Radisic, Lauren B. Skvarca, Ryan M. Hoehl, Devin A. Boyles, Jackson J. McGaughey, Brian H. Bird, Anita K. McElroy, Amy L. Hartman

    Rift Valley fever virus (RVFV) infection causes abortions in ruminant livestock and is associated with an increased likelihood of miscarriages in women. Using sheep and human placenta explant cultures, we sought to identify tissues at the maternal-fetal interface targeted by RVFV. Sheep villi and fetal membranes were highly permissive to RVFV infection resulting in markedly higher virus titers than human cultures. Sheep cultures were most permissive to wild-type RVFV and ΔNSm infection, while live attenuated RVFV vaccines (LAVs; MP-12, ΔNSs, and ΔNSs/ΔNSm) exhibited reduced replication. The human fetal membrane restricted wild-type and LAV replication, and when infection occurred, it was prominent in the maternal-facing side. Type-I and type-III interferons were induced in human villi exposed to LAVs lacking the NSs protein. This study supports the use of sheep and human placenta explants to understand vertical transmission of RVFV in mammals and whether LAVs are attenuated at the maternal-fetal interface. Teaser Vaccine strains of Rift Valley fever virus have reduced infection and replication capacity in mammalian placenta

  • Decidual Vasculopathy Identification in Whole Slide Images Using Multiresolution Hierarchical Convolutional Neural Networks

    by Daniel Clymer, Stefan Kostadinov, Janet Catov, Lauren Skvarca, Liron Pantanowitz, Jonathan Cagan, Philip LeDuc